MDXG logo

MiMedx (MDXG) EBITDA

Annual EBITDA

$40.52 M
+$51.20 M+479.20%

December 31, 2023

Summary

Performance

1-Year Change

+479.2%

3-Year Change

+186.67%

5-Year Change

+1254.18%

15-Year Change

-22.06%

MDXG EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.04%
MDXG annual EBITDA is higher than 85.04% of companies in Healthcare sector

High & Low

All-time High

$51.99 M
MDXG annual EBITDA is currently -22.06% below its historical high of $51.99 million

3-Year Low

-$10.69 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MDXG previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
MDXG next annual earnings announcement is scheduled for Feb 28, 2025

OtherMDXGprofitabilitymetrics:

Annual Revenue

$321.48 M
MDXG annual revenue is $321.48 million

Annual Net Income

$67.44 M
MDXG annual net profit is $67.44 million

Annual EBIT

$37.09 M
MDXG annual earnings before interest & taxes is $37.09 million

Annual EPS

$0.37
MDXG annual earnings per share is $0.37

Quarterly EBITDA

$12.62 M
-$11.98 M-48.72%

September 30, 2024

Summary

Performance

3-Month Change

-48.72%

1-Year Change

-8.89%

3-Year Change

+252.58%

5-Year Change

+516.89%

MDXG Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.71%
MDXG quarterly EBITDA is higher than 82.71% of companies in Healthcare sector

High & Low

All-time High

$24.60 M
MDXG quarterly EBITDA is currently -48.72% below its historical high of $24.60 million

3-Year Low

-$8.71 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MDXG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MDXG next earnings announcement is scheduled for Feb 28, 2025

OtherMDXGprofitabilitymetrics:

Quarterly Revenue

$84.06 M
MDXG quarterly revenue is $84.06 million

Quarterly Net Income

$8.10 M
MDXG quarterly net profit is $8.10 million

Quarterly EBIT

$11.46 M
MDXG quarterly earnings before interest & taxes is $11.46 million

Quarterly EPS

$0.05
MDXG quarterly earnings per share is $0.05

TTM EBITDA

$67.37 M
+$659.00 K+0.99%

September 30, 2024

Summary

Performance

3-Month Change

+0.99%

1-Year Change

+25.16%

3-Year Change

+1530.95%

5-Year Change

+625.62%

MDXG TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.51%
MDXG TTM EBITDA is higher than 85.51% of companies in Healthcare sector

High & Low

All-time High

$67.37 M
MDXG TTM EBITDA is currently at an all-time high

3-Year Low

-$20.66 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MDXG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MDXG next earnings announcement is scheduled for Feb 28, 2025

OtherMDXGprofitabilitymetrics:

TTM Revenue

$342.81 M
MDXG TTM revenue is $342.81 million

TTM Net Income

$97.67 M
MDXG TTM net profit is $97.67 million

TTM EBIT

$63.52 M
MDXG TTM earnings before interest & taxes is $63.52 million

TTM EPS

$0.61
MDXG TTM earnings per share is $0.61

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$40.52 M
MDXG annual EBITDA is $40.52 million

Annual Net Income

$67.44 M
MDXG annual net profit is $67.44 million

Annual Interest Expense

$6.46 M
MDXG annual interest expense is $6.46 million

Annual Income Tax

-$36.81 M
MDXG annual income tax is -$36.81 million

Annual D&A

$3.43 M
MDXG annual depreciation & amortization is $3.43 million

MDXG EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+479.2%-8.9%+25.2%
3 y3 years+186.7%+252.6%+1531.0%
5 y5 years+1254.2%+516.9%+625.6%

MDXG EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+479.2%-48.7%+244.9%at high+426.1%
5 y5-yearat high+186.7%-48.7%+178.5%at high+244.1%
alltimeall time-22.1%+186.7%-48.7%+178.5%at high+244.1%

MiMedx EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$12.62 M(-48.7%)
$67.37 M(+1.0%)
Jun 2024
-
$24.60 M(+77.7%)
$66.71 M(+23.9%)
Mar 2024
-
$13.85 M(-15.1%)
$53.83 M(+32.8%)
Dec 2023
$40.52 M(-479.2%)
$16.31 M(+36.4%)
$40.55 M(+11.0%)
Sep 2023
-
$11.96 M(+2.0%)
$36.52 M(+97.7%)
Jun 2023
-
$11.72 M(+1970.0%)
$18.47 M(-1046.2%)
Mar 2023
-
$566.00 K(-95.4%)
-$1.95 M(-81.9%)
Dec 2022
-$10.69 M(+465.0%)
$12.29 M(-301.5%)
-$10.79 M(-47.8%)
Sep 2022
-
-$6.10 M(-30.0%)
-$20.66 M(+42.3%)
Jun 2022
-
-$8.71 M(+5.3%)
-$14.52 M(+208.5%)
Mar 2022
-
-$8.27 M(-442.9%)
-$4.71 M(+148.8%)
Dec 2021
-$1.89 M(-96.0%)
$2.41 M(+5780.5%)
-$1.89 M(-90.0%)
Sep 2021
-
$41.00 K(-96.3%)
-$18.85 M(-46.1%)
Jun 2021
-
$1.11 M(-120.3%)
-$34.96 M(-13.1%)
Mar 2021
-
-$5.45 M(-62.5%)
-$40.24 M(-13.9%)
Dec 2020
-$46.75 M(+251.7%)
-$14.55 M(-9.4%)
-$46.75 M(+32.7%)
Sep 2020
-
-$16.07 M(+285.1%)
-$35.22 M(+1104.7%)
Jun 2020
-
-$4.17 M(-65.1%)
-$2.92 M(-78.7%)
Mar 2020
-
-$11.96 M(+295.3%)
-$13.74 M(+7.2%)
Dec 2019
-$13.29 M(-544.3%)
-$3.03 M(-118.6%)
-$12.82 M(-22.4%)
Sep 2019
-
$16.23 M(-208.3%)
-$16.51 M(-46.2%)
Jun 2019
-
-$14.99 M(+35.8%)
-$30.70 M(+145.8%)
Mar 2019
-
-$11.04 M(+64.3%)
-$12.49 M(-517.3%)
Dec 2018
$2.99 M(-94.2%)
-$6.72 M(-428.0%)
$2.99 M(-90.2%)
Sep 2018
-
$2.05 M(-36.4%)
$30.66 M(-29.0%)
Jun 2018
-
$3.22 M(-27.6%)
$43.16 M(-11.5%)
Mar 2018
-
$4.44 M(-78.8%)
$48.77 M(-6.2%)
Dec 2017
$51.99 M(+718.2%)
$20.95 M(+44.0%)
$51.99 M(+122.4%)
Sep 2017
-
$14.55 M(+64.7%)
$23.38 M(+55.8%)
Jun 2017
-
$8.84 M(+15.4%)
$15.01 M(+36.4%)
Mar 2017
-
$7.66 M(-200.0%)
$11.00 M(+73.1%)
Dec 2016
$6.35 M(-76.6%)
-$7.66 M(-224.1%)
$6.35 M(-71.8%)
Sep 2016
-
$6.17 M(+27.9%)
$22.55 M(-5.2%)
Jun 2016
-
$4.83 M(+60.4%)
$23.80 M(-5.8%)
Mar 2016
-
$3.01 M(-64.7%)
$25.27 M(-6.7%)
Dec 2015
$27.10 M
$8.54 M(+15.1%)
$27.10 M(+14.0%)
DateAnnualQuarterlyTTM
Sep 2015
-
$7.42 M(+17.6%)
$23.78 M(+15.2%)
Jun 2015
-
$6.31 M(+30.5%)
$20.63 M(+42.7%)
Mar 2015
-
$4.83 M(-7.4%)
$14.46 M(+56.7%)
Dec 2014
$9.22 M(-1073.1%)
$5.22 M(+22.0%)
$9.22 M(+200.1%)
Sep 2014
-
$4.28 M(+3240.6%)
$3.07 M(-403.1%)
Jun 2014
-
$128.00 K(-132.2%)
-$1.01 M(-31.5%)
Mar 2014
-
-$397.00 K(-57.5%)
-$1.48 M(+56.1%)
Dec 2013
-$948.00 K(-73.0%)
-$933.30 K(-595.6%)
-$947.90 K(+54.4%)
Sep 2013
-
$188.30 K(-155.8%)
-$614.10 K(-84.1%)
Jun 2013
-
-$337.40 K(-350.9%)
-$3.86 M(+21.2%)
Mar 2013
-
$134.50 K(-122.4%)
-$3.19 M(-9.2%)
Dec 2012
-$3.51 M(-56.0%)
-$599.50 K(-80.4%)
-$3.51 M(-28.3%)
Sep 2012
-
-$3.06 M(-1007.0%)
-$4.90 M(+60.3%)
Jun 2012
-
$337.60 K(-280.5%)
-$3.06 M(-43.0%)
Mar 2012
-
-$187.00 K(-90.6%)
-$5.36 M(-32.8%)
Dec 2011
-$7.98 M(-15.3%)
-$1.99 M(+62.9%)
-$7.98 M(-2.1%)
Sep 2011
-
-$1.22 M(-38.0%)
-$8.15 M(-14.2%)
Jun 2011
-
-$1.97 M(-29.9%)
-$9.50 M(-4.5%)
Mar 2011
-
-$2.81 M(+30.0%)
-$9.96 M(+5.7%)
Dec 2010
-$9.42 M(+30.5%)
-$2.16 M(-16.1%)
-$9.42 M(+29.7%)
Sep 2010
-
-$2.57 M(+6.4%)
-$7.26 M(-3.2%)
Jun 2010
-
-$2.42 M(+6.5%)
-$7.50 M(+8.6%)
Mar 2010
-
-$2.27 M(-19.3%)
-$6.91 M(-25.5%)
Dec 2009
-$7.22 M(-33.7%)
-
-
Sep 2009
-
-$2.81 M(+54.1%)
-$9.27 M(-5.3%)
Jun 2009
-
-$1.82 M(-29.7%)
-$9.79 M(-10.1%)
Mar 2009
-
-$2.59 M(+27.3%)
-$10.89 M(+31.3%)
Mar 2009
-$10.89 M(+7.0%)
-
-
Dec 2008
-
-$2.04 M(-38.8%)
-$8.29 M(+32.4%)
Sep 2008
-
-$3.33 M(+13.8%)
-$6.26 M(+113.1%)
Jun 2008
-
-$2.93 M(>+9900.0%)
-$2.94 M(+7884.5%)
Mar 2008
-$10.17 M(>+9900.0%)
-
-
Dec 2007
-$36.80 K(+128.6%)
-$7400.00(+48.0%)
-$36.80 K(+25.2%)
Sep 2007
-
-$5000.00(-41.2%)
-$29.40 K(+20.5%)
Jun 2007
-
-$8500.00(-46.5%)
-$24.40 K(+53.5%)
Mar 2007
-
-$15.90 K
-$15.90 K
Dec 2006
-$16.10 K
-
-

FAQ

  • What is MiMedx annual EBITDA?
  • What is the all time high annual EBITDA for MiMedx?
  • What is MiMedx annual EBITDA year-on-year change?
  • What is MiMedx quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MiMedx?
  • What is MiMedx quarterly EBITDA year-on-year change?
  • What is MiMedx TTM EBITDA?
  • What is the all time high TTM EBITDA for MiMedx?
  • What is MiMedx TTM EBITDA year-on-year change?

What is MiMedx annual EBITDA?

The current annual EBITDA of MDXG is $40.52 M

What is the all time high annual EBITDA for MiMedx?

MiMedx all-time high annual EBITDA is $51.99 M

What is MiMedx annual EBITDA year-on-year change?

Over the past year, MDXG annual EBITDA has changed by +$51.20 M (+479.20%)

What is MiMedx quarterly EBITDA?

The current quarterly EBITDA of MDXG is $12.62 M

What is the all time high quarterly EBITDA for MiMedx?

MiMedx all-time high quarterly EBITDA is $24.60 M

What is MiMedx quarterly EBITDA year-on-year change?

Over the past year, MDXG quarterly EBITDA has changed by -$1.23 M (-8.89%)

What is MiMedx TTM EBITDA?

The current TTM EBITDA of MDXG is $67.37 M

What is the all time high TTM EBITDA for MiMedx?

MiMedx all-time high TTM EBITDA is $67.37 M

What is MiMedx TTM EBITDA year-on-year change?

Over the past year, MDXG TTM EBITDA has changed by +$13.54 M (+25.16%)